Format

Send to

Choose Destination
See comment in PubMed Commons below
Orbit. 2005 Jun;24(2):117-9.

Infliximab: a novel treatment for sight-threatening thyroid associated ophthalmopathy.

Author information

1
Academic Unit of Ophthalmology, the University of Birmingham, UK.

Abstract

We describe a patient with sight threatening thyroid associated ophthalmopathy (TAO) who was successfully treated with infliximab, an anti-tumour necrosis factor (TNF)-a antibody.

PMID:
16191800
DOI:
10.1080/01676830590912562
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center